PedroPiedraMD
Pediatric Infectious Disease • Houston, TXProfessor, Virology & Microbiology, Baylor College of Medicine
Dr. Piedra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1504 Taub Loop
Houston, TX 77030Phone+1 713-873-5437Fax+1 713-873-4337
Education & Training
University at BuffaloFellowship, Pediatric Infectious Diseases, 1984 - 1987
Medical University of South CarolinaResidency, Pediatrics, 1981 - 1984
University of South Florida College of MedicineClass of 1981
Certifications & Licensure
TX State Medical License 1988 - 2025
SC State Medical License 1982 - 1984- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Publications & Presentations
PubMed
- Nasal microbionts differentially colonize and elicit cytokines in human nasal epithelial organoids.Andrea I Boyd, Leah A Kafer, Isabel F Escapa, Amal Kambal, Hira Tariq
Biorxiv. 2024-09-25 - 5 citationsThe Efficiency of p27 Cleavage duringRespiratory Syncytial Virus (RSV) Infection Is Cell Line and RSV Subtype Dependent.Wanderson Rezende, Xunyan Ye, Laura S Angelo, Alexandre F Carisey, Vasanthi Avadhanula
Journal of Virology. 2023-05-31 - 8 citationsSustained Within-season Vaccine Effectiveness Against Influenza-associated Hospitalization in Children: Evidence From the New Vaccine Surveillance Network, 2015-2016 T...Leila C Sahni, Eric A Naioti, Samantha M Olson, Angela P Campbell, Marian G Michaels
Clinical Infectious Diseases. 2023-02-08
Other
- Respiratory Syncytial Virus Fusion Nanoparticle Vaccine Immune Responses Target Multiple Neutralizing Epitopes That Contribute to Protection Against Wild-Type and Pali...Pedro Piedra, MD, ScienceDirect
https://www.doximity.com/articles/ec82b951-b191-4406-8038-7129da66ac6c
UpToDate, Wolters Kluwer Health - 2013-03-13 - Respiratory Syncytial Virus Fusion Nanoparticle Vaccine Immune Responses Target Multiple Neutralizing Epitopes That Contribute to Protection Against Wild-Type and Pali...Pedro Piedra, MD, ScienceDirect
https://www.doximity.com/articles/ec82b951-b191-4406-8038-7129da66ac6c
UpToDate, Wolters Kluwer Health - 2013-01-09
Press Mentions
More Information Needed Amid Paused RSV Vaccine for Children, FDA Committee SaysDecember 14th, 2024
FluMist: Who Is the Nasal Spray Best For?October 22nd, 2024- COVID, Flu and RSV: Know the Vaccines for These Three Common Respiratory VirusesSeptember 4th, 2024
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
